Instillation of Bacillus Calmette-Guerin into the Renal Pelvis of A Solitary Kidney for the Treatment of Transitional Cell Carcinoma
- 1 June 1990
- journal article
- case report
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 143 (6) , 1220-1222
- https://doi.org/10.1016/s0022-5347(17)40230-8
Abstract
Intravesical bacillus Calmette-Guerin is effective in the treatment and prophylaxis of superficial urothelial cancer of the bladder. There have been few reports of its efficacy and toxicity when instilled into the upper urinary tract. We elected to use intracavitary bacillus Calmette-Guerin in a patient with recurrent high grade transitional cell carcinoma in the renal pelvis of a solitary autotransplanted kidney. The patient required hospitalization and triple-drug therapy after 5 instillations. She was free of tumor 1 year after bacillus Calmette-Guerin instillations.Keywords
This publication has 7 references indexed in Scilit:
- Percutaneous Management of Renal Pelvic Tumors: A Treatment Option in Selected CasesJournal of Urology, 1987
- Percutaneous Management of Upper Tract Transitional Cell CarcinomaJournal of Urology, 1986
- Local Excision and Topical Thiotepa in the Treatment of Transitional Cell Carcinoma of the Renal Pelvis: a Case ReportJournal of Urology, 1986
- Complications of Bacillus Calmette-Guerin Immunotherapy in 1,278 Patients with Bladder CancerJournal of Urology, 1986
- Durable Response of a Carcinoma in Situ of the Renal Pelvis to Topical Bacillus Calmette-GuerinJournal of Urology, 1985
- Endoscopic diagnosis and treatment of upper-tract urothelial tumors. A preliminary reportCancer, 1985
- Bilateral Primary Carcinoma of the Ureter: Topical Intraureteral ThiotepaJournal of Urology, 1984